8189 — Tianjin TEDA Biomedical Engineering Co Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapNeutral

Market Cap
HK$153.50m
Enterprise Value
HK$252.74m
Revenue
CNY398.00m

Annual balance sheet for Tianjin TEDA Biomedical Engineering Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	24.9	35.5	29.8	9.55	5.93
Net Total Accounts Receivable
Net Total Receivables	84.4	59	42.9	45.1	18.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	254	260	209	193	190
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	69.3	126	139	132	113
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	362	393	348	337	303
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	156	194	192	218	217
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	171	250	247	267	253
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	191	143	101	70.1	50
Total Liabilities & Shareholders' Equity	362	393	348	337	303
Total Common Shares Outstanding